Now Enrolling Learn More Now Enrolling Learn More Now Enrolling Learn More Latest News Jun 2, 2021 Abeona Therapeutics to Present at Jefferies Virtual Healthcare Conference View Press Release May 26, 2021 Abeona Therapeutics Issues Letter to Stockholders View Press Release May 25, 2021 Abeona Therapeutics Appoints Head of Research & Clinical Development View Press Release View All Our inspiration Learn More Pipeline Our clinical-stage therapies are designed to deliver functional copies of affected genes to cells using gene transfer technologies. Explore R&D EB-101 In Phase 3 development. Autologous gene-corrected cell therapy for patients with RDEB. Learn More ABO-102 In Phase 1/2 development. One-time, AAV-based gene therapy for patients with Sanfilippo syndrome type A (MPS IIIA). Learn More ABO-101 In Phase 1/2 development. One-time, AAV-based gene therapy for patients with Sanfilippo syndrome type B (MPS IIIB). Learn More Manufacturing at The Elisa Linton Center for Rare Disease Therapies Learn More
